Newsletter Signup

Jenex Received Results on TherOZap Technology

1024 379 Techna

3127

Techna was engaged by Jenex to assess their TherOZaptechnology for the inactivation of Zika virus in cultured cells. The study is now complete and Jenex has received the results — read the summary of the study in Jenex’s press release here.